Science
LambdaVision to Study Light-Activated Proteins on NASA’s Upcoming Flight to International Space Station – Business Wire
LambdaVision, an innovative biotech developing a treatment to help patients regain sight, will launch their artificial retina technology with engineer
FARMINGTON, Conn.–(BUSINESS WIRE)–LambdaVision, an innovative biotech developing a treatment to help patients regain sight, will launch their artificial retina technology with engineering partner Space Tango on Northrop Grummans 14th Commercial Resupply Services Mission for NASA (NG-14) to the International Space Station (ISS) U.S. National Laboratory. Scheduled to launch on September 30th at 2:26 UTC (10:26 p.m. ET), NG-14 is the first of a series of NASA flights to the ISS in low-Earth orbit…
-
Business23 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?
-
General23 hours agoTop chess player Magnus Carlsen forced into draw in historic game against over 134,000 people
-
Noosa News9 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
General23 hours agoTaiwan’s President Lai Ching-te calls for peace and dialogue with China while also calling for defence boosts